- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03614312
Placenta Development Study
December 18, 2023 updated by: Arkansas Children's Hospital Research Institute
Epigenetic Mechanisms Underlying Trophoblast Syncytialization
This study will help us learn more about how the placenta develops.
Study Overview
Status
Completed
Conditions
Detailed Description
The primary purpose of this study is to understand the epigenetic signaling events in placental trophoblast development.
Study Type
Observational
Enrollment (Actual)
15
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72202
- Arkansas Children's Nutrition Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Pregnant
Description
Inclusion Criteria:
- BMI - 18-25 kg/m2
- at least 18 years of age
- singleton pregnancy
- less than 36 weeks and plan to deliver in the Little Rock/North Little Rock Area
Exclusion Criteria:
- Women with pre-existing medical conditions (e.g. diabetes, hypertension, pre-eclampsia, STD, gestational diabetes)
- Women who are using recreational drugs, tobacco, or alcohol during their pregnancy.
- Women who plan on keeping their placenta following delivery for non-medical reasons.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
BMI 18-25 Pregnant Women
BMI 18-25 less than 36 weeks pregnant
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants that placental syncytial fusion involves epigenetic changes in histone modifications
Time Frame: 40 weeks
|
Number of participants that histone acetyltransferases eszymes, CBP and p300 affect syncytial fusion
|
40 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 17, 2018
Primary Completion (Actual)
December 22, 2021
Study Completion (Actual)
December 22, 2021
Study Registration Dates
First Submitted
March 5, 2018
First Submitted That Met QC Criteria
July 30, 2018
First Posted (Actual)
August 3, 2018
Study Record Updates
Last Update Posted (Estimated)
December 20, 2023
Last Update Submitted That Met QC Criteria
December 18, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 206617
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.